
On nuclear medicine and oncology, SHINE Technologies
Greg Piefer, founder and CEO of SHINE Technologies, discusses nuclear medicine and the role of radiopharmaceuticals in oncology.
Newsletters and Deep Dive digital magazine
Greg Piefer, founder and CEO of SHINE Technologies, discusses nuclear medicine and the role of radiopharmaceuticals in oncology.
Deep Dive editor Eloise McLennan debriefs on the key themes, hot topics, and hallway conversations that shaped the HLTH event in Amsterdam.
Marc Buyse, founder of IDDI and One2Treat, and also co-founder of CluePoints, discusses the pressing need for quantitative methodologies.
Novo Nordisk and Veeva have entered into a new partnership for clinical development.
In a new pharmaphorum podcast, Tommy Bramley, SVP of market access and healthcare consulting at Cencora, discusses Joint Clinical Assessments.
Editor's Picks
Newsletters and Deep Dive
digital magazine